Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mixed Hyperlipoproteinemia”

77 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 77 results

Not applicableLooking for participantsNCT06752772
What this trial is testing

WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study

Who this might be right for
Elevated Blood PressureHypertensionOverweight/Obesity+3 more
Alexandra Hospital 1,700
Large-scale testing (Phase 3)Study completedNCT00139061
What this trial is testing

Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate

Who this might be right for
Hyperlipidemia
Pfizer 128
Not applicableUnknownNCT03274089
What this trial is testing

Health Outcomes of Patients With Stable Chronic Disease Managed With a Healthcare Kiosk

Who this might be right for
HypertensionHyperlipidemia; MixedDiabetes Mellitus
SingHealth Polyclinics 120
Large-scale testing (Phase 3)Study completedNCT00138762
What this trial is testing

Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol

Who this might be right for
Hyperlipidemia
Pfizer 3,800
Testing effectiveness (Phase 2)Ended earlyNCT00325455
What this trial is testing

MK0859 Dose-Ranging Study (0859-003)

Who this might be right for
HypercholesterolemiaMixed Hyperlipemia
Merck Sharp & Dohme LLC 500
Large-scale testing (Phase 3)Study completedNCT00378833
What this trial is testing

Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054)

Who this might be right for
HypercholesterolemiaHyperlipidemia
Merck Sharp & Dohme LLC 1,300
Testing effectiveness (Phase 2)Study completedNCT04516291
What this trial is testing

A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)

Who this might be right for
DyslipidemiasHyperlipidemiasHyperlipoproteinemias
Pfizer 286
Large-scale testing (Phase 3)Study completedNCT00092573
What this trial is testing

Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)

Who this might be right for
HypercholesterolemiaHypertriglyceridemia
Organon and Co 576
Testing effectiveness (Phase 2)Study completedNCT05256654
What this trial is testing

LY3561774 in Participants With Mixed Dyslipidemia

Who this might be right for
DyslipidemiasLipid Metabolism DisordersMetabolic Diseases+1 more
Eli Lilly and Company 205
Large-scale testing (Phase 3)Not Yet RecruitingNCT07421284
What this trial is testing

Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy

Who this might be right for
Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 900
Early research (Phase 1)Looking for participantsNCT07491172
What this trial is testing

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

Who this might be right for
CardiovascularMetabolic DiseaseDyslipidemias+7 more
CRISPR Therapeutics AG 90
Large-scale testing (Phase 3)Looking for participantsNCT06568471
What this trial is testing

A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia

Who this might be right for
HypercholesterolemiaDyslipidemiasPrimary Hypercholesterolemia+4 more
Hasten Biopharmaceutical Co., Ltd. 210
Post-approval studies (Phase 4)WithdrawnNCT02069106
What this trial is testing

Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction

Who this might be right for
Mixed Hyperlipoproteinemia
Nordic Pharma, USA
Large-scale testing (Phase 3)WithdrawnNCT02947334
What this trial is testing

Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects

Who this might be right for
Primary Hyperlipidemia or Mixed Dyslipidemia
Pfizer
Large-scale testing (Phase 3)Study completedNCT00269204
What this trial is testing

Lipid Efficacy/Tolerability Study (0524A-020)

Who this might be right for
Primary HypercholesterolaemiaMixed Hyperlipidaemia
Merck Sharp & Dohme LLC 1,620
Large-scale testing (Phase 3)Not Yet RecruitingNCT07444086
What this trial is testing

QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
Primary Hypercholesterolemia or Mixed Hyperlipidemia
Qilu Pharmaceutical Co., Ltd. 510
Large-scale testing (Phase 3)Study completedNCT02189837
What this trial is testing

Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody

Who this might be right for
Primary Hyperlipidemia and Mixed Dyslipidemia
Amgen 89
Post-approval studies (Phase 4)UnknownNCT01010516
What this trial is testing

Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia

Who this might be right for
Dyslipidemia
University of Ioannina 120
Large-scale testing (Phase 3)Study completedNCT01854918
What this trial is testing

Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia

Who this might be right for
Hyperlipidemia and Mixed Dyslipidemia
Amgen 3,681
Large-scale testing (Phase 3)Study completedNCT00349375
What this trial is testing

Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy

Who this might be right for
Hyperlipidemia
Solvay Pharmaceuticals 1,040
Next Page